Aclairo

At Golden Health Holistics, we care about your total well-being. We are a holistic wellness center in Sterling, Virginia, utilizing evidence-based functional lab testing to help identify underlying root causes of health issues. Our team of nutritionists, pharmacists, herbalists, and health coache...

Founded in 1987, MedImmune is a pharmaceutical health care company that develops medications for the treatment of cancer, inflammatory diseases and pediatric infections. The company markets products under the trade names of Synagis, Ethyol, FluMist and CytoGam. With more than 3,000 employees, it has operations in the United States, the United Kingdom and the Netherlands. MedImmune offers a selection of clinical testing products for the detection of cardiovascular and gastrointestinal diseases. The company provides the HUMIRA brand of medicine for the treatment of crohn's disease, ankylosing spondylitis rheumatoid, chronic plaque psoriasis and juvenile rheumatoid arthritis. In addition, it assists with the development of investigational human monoclonal antibodies for targeting interferon alpha in patients with systemic lupus erythematosus.

Incorporated in 1989, Otsuka America Pharmaceutical is a health care company that commercializes its products throughout North America. It offers products under the ABILIFY Tablets1 and PLETAL Tablets2 brands. The company works in collaboration with Bristol-Myers Squibb, which co-develops and co-promotes ABILIFY. Otsuka America Pharmaceutical has also merged with Meretek Diagnostics to form the Meretek Diagnostics Group under the Medical Device Division of OAPI. It focuses on neuroscience, cardiovascular, oncologic and gastrointestinal therapeutic treatments. The company operates Otsuka Maryland Research Institute, which was established as a wholly-owned subsidiary of OAPI to research and develop a variety of health care products. Otsuka America Pharmaceutical is a part of Otsuka Pharmaceutical Group.